A top strategist at JPMorgan Asset Management said on CNBC Wednesday that the Federal Reserve is “fundamentally making a mistake” with its anticipated rate cut at the end of the month.

David Kelly, the chief global strategist at JPMorgan Asset Management, said on CNBC’s “Power Lunch” that he doesn’t think rate cuts will boost the United States economy and that the expected cut is in part due to political pressure from the Trump administration on Fed Chair Jerome Powell.

“Chairman Powell admits that really it is fiscal policy that has any possibility at all of stimulating the economy,” Kelly said. “Not, by the way, that you need to stimulate the economy when you’ve got a 3.7% unemployment rate.”

President Donald Trump has reportedly discussed attempting to remove Powell from his position. Powell reiterated on Wednesday during a Congressional hearing that he intends to serve his entire term and said “my answer would be no ” to an attempt by Trump to fire him.

“I think they’re worried about independence. I think they’re worried about getting too criticized by the administration,” Kelly said.

Kelly also said members of the Fed “seem obsessed” with inflation, which has remained below the target rate of 2%.

“That’s a slippery slope. We may not get to 2% inflation. Does that justify October? Does that justify December? You could go all the way down to zero on the Federal Funds Rate and not get to 2% inflation,” Kelly said.

The overwhelming expectation in the market is for the Fed to cut interest rates at its meeting on July 30 and 31.The S&P 500 reached record highs on Wednesday when it became clear that Powell would not try to dissuade the market of that expectation in his Congressional testimony.

Products You May Like

Articles You May Like

Retirement savers moving some money out of stocks, says Fidelity’s personal investing president
Don’t make this $42,000 mistake
This Midwestern city is home of the 500, the Colts and one breathtaking church sale
FA 100: CNBC ranks the top-rated financial advisory firms of 2019
Top drug distributors in talks to settle opioid litigation for $18 billion, report says

Leave a Reply

Your email address will not be published. Required fields are marked *